SCHEMBL7328156

SCHEMBL7328156

CCOC(=O)C1=C(COC(N)=O)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.78
CYP3A4 P08684 3/20 0.78
TBXA2R P21731 3/20 0.78
ADRA1A P35348 3/20 0.78
SLC6A3 Q01959 3/20 0.78
ABCB11 O95342 3/20 0.78
KDM4E B2RXH2 3/20 0.78
ADORA3 P0DMS8 3/20 0.78
TSHR P16473 3/20 0.78
MEN1 O00255 2/20 0.78
CYP1A2 P05177 2/20 0.78
CYP2C19 P33261 2/20 0.78
KMT2A Q03164 2/20 0.78
HIF1A Q16665 2/20 0.78
HSD17B10 Q99714 2/20 0.78
ABCB1 P08183 2/20 0.78
ADRB3 P13945 2/20 0.78
OPRK1 P41145 2/20 0.78
SCN5A Q14524 2/20 0.78
NR1I2 O75469 2/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11038359 0.96 CYP2C9 (0.71) CYP2C9CYP3A4TBXA2RADRA1ASLC6A3
SCHEMBL7330272 0.96 CYP2C9 (0.71) CYP2C9CYP3A4TBXA2RADRA1ASLC6A3
SCHEMBL7318977 0.93 CYP2C9 (0.68) CYP2C9CYP3A4TBXA2RADRA1ASLC6A3
SCHEMBL11357080 0.93 CYP2C9 (0.83) CYP2C9CYP3A4TBXA2RADRA1ASLC6A3
SCHEMBL7320948 0.92 CYP2C9 (0.66) CYP2C9CYP3A4TBXA2RADRA1ASLC6A3
SCHEMBL9501593 0.90 KDM4E (0.85) CYP2C9CYP3A4TBXA2RADRA1ASLC6A3
Lemildipine SCHEMBL49443 0.89 CYP2C9 (0.62) CYP2C9CYP3A4TBXA2RADRA1ASLC6A3
Lemildipine SCHEMBL49442 0.89 CYP2C9 (0.62) CYP2C9CYP3A4TBXA2RADRA1ASLC6A3
SCHEMBL10888067 0.89 CYP2C9 (0.74) CYP2C9CYP3A4TBXA2RADRA1ASLC6A3
Lemildipine SCHEMBL29801339 0.89 CYP2C9 (0.62) CYP2C9CYP3A4TBXA2RADRA1ASLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5494923-A Method of ameliorating cerebral circulation BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-02-27 US disclosed
US-5444077-A Ameliorant of cerebral circulation and optical isomer of NB-818, processes for its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-22 US disclosed
EP-0311053-A2 Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-04-12 EP disclosed